newsfilter
← Latest News
PR Newswire·

Launch of Phase 3 clinical trial with Nefecon in Japan

Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ...